A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Metformin in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Metformin in Subjects With Type 2 Diabetes Mellitus
This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to determine the effect of ranolazine when added to metformin on glycemic control in adults with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current treatment with stable metformin therapy in addition to diet and exercise.
Inclusion Criteria:
Exclusion Criteria:
Little Rock, Alaska 72205, United States
Sugarland, Texas 77479, United States
Hyderabad, Andhra Pradesh 500034, India
Nagpur, Maharashtra 440010, India
Chandigarh, Punjab 160017, India
Bialystok, 15-435, Poland
Lodz, Łódź Voivodeship 90242, Poland
Saint Petersburg, 197341, Russia
Saint Petersburg, 198013, Russia
Kwa Zulu Natal, Durban 4091, South Africa
Kwa Zulu Natal, 4170, South Africa
Kwa Zulu Natal, 4320, South Africa
Kharkiv, 61002, Ukraine
Kyiv, 02175, Ukraine
Kyiv, 03049, Ukraine
Kyiv, 04050, Ukraine
Kyiv, 04050, Ukraine